Walking away from pain: new hope for veterans with opioid addiction
NCT ID NCT05051644
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a walking program for veterans with opioid use disorder and chronic pain. Sixty veterans receiving medication for opioid addiction took part. The program included pain education and a step-by-step walking plan using a pedometer. The goal was to see if this approach was feasible and acceptable for managing pain.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- behavioral intervention: pain education and a pedometer-assisted walking program
- What this could lead to
- If successful, this could offer a simple, non-drug way to help people with opioid use disorder cope with chronic pain.
- What could go wrong
- This was a very small, early-phase study with only 60 participants, so results may not apply to everyone. The walking program may not work for all types of pain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
West Haven, Connecticut, 06516-2770, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mind-Body physio program aims to tackle chronic pain and depression together
- Can we decode the different types of pain in multiple sclerosis?
- Can yoga ease the pain of endometriosis after surgery?
- A simple pressure test before surgery might reveal your risk of chronic pain
- Rewiring the brain to fight back pain?
- Can a new tool better measure opioid withdrawal?